Clinical Trials at AIM Centre
During the past decade, AIM Centre conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "AIM Centre"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "Southern Star Research Pty Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at AIM Centre
According to Clinical.Site data, the most researched conditions in "AIM Centre" are
"Type 2 Diabetes Mellitus" (2 trials), "Diabetes Mellitus Type 1" (1 trials), "Diabetes Mellitus, Type 1" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Overweight and Obesity" (1 trials). Many other conditions were trialed in "AIM Centre" in a lesser frequency.
Clinical Trials Intervention Types at AIM Centre
Most popular intervention types in "AIM Centre" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Empagliflozin" (1 trials), "GNbAC1" (1 trials), "Insulin Glargine" (1 trials) and "Insulin Lispro" (1 trials). Other intervention names were less common.
Clinical Trials Genders at AIM Centre
The vast majority of trials in "AIM Centre" are
6 trials for "All" genders.
Clinical Trials Status at AIM Centre
Currently, there are NaN active trials in "AIM Centre".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in AIM Centre,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in AIM Centre, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".